Found: 7
Select item for more details and to access through your institution.
Efficacy and safety of elobixibat in combination with or switched from conventional treatments of chronic constipation: A retrospective observational study.
- Published in:
- JGH Open, 2024, v. 8, n. 8, p. 1, doi. 10.1002/jgh3.70019
- By:
- Publication type:
- Article
Impact on prognosis of rebiopsy in advanced non-small cell lung cancer patients after epidermal growth factor receptor-tyrosine kinase inhibitor treatment: a systematic review.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Propensity score matching analysis: incidence and risk factors for "stardust" gastric mucosa, a novel gastric finding potentially induced by vonoprazan.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 1, p. 94, doi. 10.1111/apt.16151
- By:
- Publication type:
- Article
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium.
- Published in:
- Nature Medicine, 2007, v. 13, n. 4, p. 470, doi. 10.1038/nm1566
- By:
- Publication type:
- Article
Real-World Comparison of Elobixibat and Lubiprostone Treatment in Patients with Chronic Constipation: A Propensity Score-Matched Analysis.
- Published in:
- Digestive Diseases, 2021, v. 39, n. 4, p. 341, doi. 10.1159/000512745
- By:
- Publication type:
- Article
Risk Factors for Adverse Events in Patients with Chronic Constipation Following Lubiprostone Administration.
- Published in:
- Digestive Diseases, 2021, v. 39, n. 1, p. 10, doi. 10.1159/000508864
- By:
- Publication type:
- Article
Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression.
- Published in:
- International Journal of Cancer, 2008, v. 123, n. 12, p. 2735, doi. 10.1002/ijc.23853
- By:
- Publication type:
- Article